References

Acierno MJ, Brown S, Coleman AE ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018; 32:(6)1803-1822 https://doi.org/10.1111/jvim.15331

Andrew R, Harvey AM, Tasker S. Primary hyperaldosteronism in the cat: a series of 13 cases. J Feline Med Surg. 2005; 7:(3)173-182 https://doi.org/10.1016/j.jfms.2004.08.007

Belew AM, Barlett T, Brown SA. Evaluation of the white-coat effect in cats. J Vet Intern Med. 1999; 13:(2)134-142 https://doi.org/10.1111/j.1939-1676.1999.tb01141.x

Bijsmans ES, Jepson RE, Chang YM, Syme HM, Elliott J. Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease. J Vet Intern Med. 2015; 29:(3)855-861 https://doi.org/10.1111/jvim.12600

Brown AL, Beatty JA, Lindsay SA, Barrs VR. Severe systemic hypertension in a cat with pituitary-dependent hyperadrenocorticism. J Small Anim Pract. 2012; 53:(2)132-135 https://doi.org/10.1111/j.1748-5827.2011.01150.x

Calsyn JDR, Green RA, Davis GJ, Reilly CM. Adrenal pheochromocytoma with contralateral adrenocortical adenoma in a cat. J Am Anim Hosp Assoc. 2010; 46:(1)36-42 https://doi.org/10.5326/0460036

Ocular manifestations of systemic hypertension. 2019. https://www.vetprofessionals.com/site/downloads/free/Ocular%20manifestations%20of%20systemic%20hypertension%202019.pdf (accessed 17 November 2021)

Caney SMA. Management of hypertension in cats. In: Elliot J, Syme H, Jepson R (eds). : Springer Nature Switzerland AG; 2020

Chalhoub S, Langston CE, Farrelly J. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases. J Vet Intern Med. 2012; 26:(2)363-369 https://doi.org/10.1111/j.1939-1676.2011.00864.x

Chetboul V, Lefebvre HP, Pinhas C Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. J Vet Intern Med. 2003; 17:(1)89-95 https://doi.org/10.1892/0891-6640(2003)017%3C0089:sfhcae%3E2.3.co;2

Chun R, Jakovljevic S, Morrison WB, DeNicola DB, Cornell KK. Apocrine gland adenocarcinoma and pheochromocytoma in a cat. J Am Anim Hosp Assoc. 1997; 33:(1)33-36 https://doi.org/10.5326/15473317-33-1-33

Conroy M, Chang YM, Brodbelt D, Elliott J. Survival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom. J Vet Intern Med. 2018; 32:(6)1846-1855 https://doi.org/10.1111/jvim.15307

Cowgill LD, James KM, Levy JK Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc. 1998; 212:(4)521-528

Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract. 2001; 42:(3)122-129 https://doi.org/10.1111/j.1748-5827.2001.tb02008.x

Henry CJ, Brewer WG, Montgomery RD Clinical vignette – adrenal phaeochromocytoma in a cat. J Vet Intern Med. 1993; 7:(3)199-201 https://doi.org/10.1111/j.1939-1676.1993.tb03188.x

Javadi S, Djajadiningrat-Laanen SC, Kooistra HS Primary hyperaldosteronism, a mediator of progressive renal disease in cats. Domest Anim Endocrinol. 2005; 28:(1)85-104 https://doi.org/10.1016/j.domaniend.2004.06.010

Jepson RE, Elliott J, Brodbelt D, Syme HM. Effect of control of systolic blood pressure on survival in cats with systemic hypertension. J Vet Intern Med. 2007; 21:(3)402-409 https://doi.org/10.1892/0891-6640(2007)21[402:eocosb]2.0.co;2

Kobayashi DL, Peterson ME, Graves TK, Lesser M, Nichols CE. Hypertension in cats with chronic renal failure or hyperthyroidism. J Vet Intern Med. 1990; 4:(2)58-62 https://doi.org/10.1111/j.1939-1676.1990.tb03104.x

Littman MP. Spontaneous systemic hypertension in 24 cats. J Vet Intern Med. 1994; 8:(2)79-86 https://doi.org/10.1111/j.1939-1676.1994.tb03202.x

Maggio F, DeFrancesco TC, Atkins CE Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc. 2000; 217:(5)695-702 https://doi.org/10.2460/javma.2000.217.695

Morrow LD, Adams VJ, Elliott J Hypertension in hyperthyroid cats: prevalence, incidence and predictors of its development. J Vet Intern Med. 2009; 23

Patnaik AK, Erlandson RA, Lieberman PH, Welches CD, Marretta SM. Extra-adrenal pheochromocytoma (paraganglioma) in a cat. J Am Vet Med Assoc. 1990; 197:104-106

Stiles J, Polzin DJ, Bistner SI. The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J Am Vet Med Assoc. 1994; 30:(6)564-572

Syme HM, Elliott J. The prevalence of hypertension in hyperthyroid cats at diagnosis and following treatment. J Vet Intern Med. 2003; 17

Taylor SS, Sparkes AH, Briscoe K ISFM Consensus guidelines on the diagnosis and management of hypertension in cats. J Feline Med Surg. 2017; 19:(3)288-303 https://doi.org/10.1177/1098612x17693500

van Haaften KA, Forsythe LRE, Stelow EA, Bain MJ. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc. 2017; 251:(10)1175-1181 https://doi.org/10.2460/javma.251.10.1175

Williams TL, Peak KJ, Brodbelt D, Elliott J, Syme HM. Survival and the development of azotemia after treatment of hyperthyroid cats. J Vet Intern Med. 2010; 24:(4)863-869 https://doi.org/10.1111/j.1939-1676.2010.0550.x

Wimpole JA, Adagra CF, Billson MF, Pillai DN, Foster DJ. Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma. J Feline Med Surg. 2010; 12:(6)435-440 https://doi.org/10.1016/j.jfms.2009.10.010

Feline blood pressure measurement: when is it needed?

02 December 2021
14 mins read
Volume 26 · Issue 11
Figure 1. Blood pressure measurement using Doppler methodology.
Figure 1. Blood pressure measurement using Doppler methodology.

Abstract

Systemic hypertension is a common disorder, primarily affecting older cats. Most cases are secondary to underlying medical conditions, such as chronic kidney disease. If left untreated, systemic hypertension has the potential to cause serious damage to certain target organs and can be fatal. Target organs include the nervous system, cardiovascular system, eyes and kidneys. Target organ damage to the eyes is often pathognomonic and is detected on ophthalmological examination in up to 80% of cats with systemic hypertension. Blood pressure measurement is essential in confirming a diagnosis and should be prioritised in cats showing evidence of target organ damage. Blood pressure screening of apparently healthy older cats is justified, since the risk of hypertension increases with age. Systemic hypertension is diagnosed in cats with persistent elevation in their systolic blood pressure of 160 mmHg or higher. Stress and anxiety can cause a transient increase in systolic blood pressure so measurements should be collected in a manner that is as calm and ‘cat friendly’ as possible. In the presence of confirmed target organ damage, a single high systolic blood pressure reading confirms systemic hypertension. Where no target organ damage is detectable, evidence of elevated systolic blood pressure on two or more occasions is needed to confirm the diagnosis.

Systemic hypertension, a persistent increase in the systemic blood pressure above 160 mmHg systolic, is now commonly recognised in feline practice. There are several reasons for this, including an increased awareness of hypertension as a feline problem, increased access to diagnostic facilities and potentially, an increased prevalence of this condition related to the increasing age of the cat population – with current estimates of its prevalence at approximately 20% of cats aged 9 years and over (Conroy et al, 2018).

An age-related increase in systolic blood pressure has been reported (Bijsmans et al, 2015), meaning that older cats are at an increased risk of developing systemic hypertension. Its onset is also often associated with other conditions, many of which increase in prevalence with age, further increasing the risk to older cats. As an example, one study of 58 cats with systemic hypertension reported their mean age to be 13 years (Chetboul et al, 2003). The most commonly associated illnesses are chronic kidney disease and hyperthyroidism. Prevalence rates reported have been highly variable, for example, 20–65% of cats with chronic kidney disease are diagnosed with concurrent systemic hypertension, compared to 9–23% of newly diagnosed hyperthyroid cats (Kobayashi et al, 1990; Littman, 1994; Stiles et al, 1994; Syme et al, 2002; Syme and Elliott, 2003; Morrow et al, 2009; Williams et al, 2010). Other diseases that have been associated with hypertension in cats include primary hyperaldosteronism (Conn's syndrome), phaeochromocytoma, therapy with erythrocyte stimulating agents and occasionally, hyperadrenocorticism (Patnaik et al, 1990; Henry et al, 1993; Chun et al, 1997; Cowgill et al, 1998; Ash et al, 2005; Javadi et al, 2005; Calsyn et al, 2010; Wimpole et al, 2010; Brown et al, 2012; Chalhoub et al, 2012).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.